Samrat Pharmachem Ltd.
BSE: 530125 | Sector: Health care |
NSE: N.A. | ISIN Code: INE103E01016 |
BSE 00:00 | 05 Jul | 452.40 |
11.25 (2.55%) |
OPEN
449.90 |
HIGH
459.30 |
LOW
433.00 |
NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
OPEN | 449.90 |
PREVIOUS CLOSE | 441.15 |
VOLUME | 3602 |
52-Week high | 578.00 |
52-Week low | 170.00 |
P/E | 8.13 |
Mkt Cap.(Rs cr) | 140 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Samrat Pharmachem Ltd. (SAMRATPHARMA) - Profit And Loss
Figures in Rs crore | 2021 | 2020 | 2019 |
Income | |||
Sales Turnover | 204.37 | 157.12 | 125.36 |
Excise Duty | 25.35 | 19.66 | 14.22 |
Net Sales | 179.02 | 137.46 | 111.14 |
Other Income | 0.46 | 0.57 | 0.46 |
Stock Adjustments | -2.23 | 6.18 | 0.91 |
Total Income | 177.25 | 144.21 | 112.51 |
Expenditure | |||
Raw Materials | 162.02 | 131.80 | 103.53 |
Power & Fuel Cost | 1.12 | 0.91 | 0.73 |
Employee Cost | 1.05 | 1.00 | 0.94 |
Other Manufacturing Expenses | 1.78 | 1.34 | 1.52 |
Selling and Administration Expenses | 1.79 | 1.83 | 2.09 |
Miscellaneous Expenses | 0.38 | 0.13 | 0.05 |
less: Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 |
Total Expenditure | 168.14 | 137.01 | 108.86 |
Operating Profit | 9.11 | 7.20 | 3.64 |
Interest | 1.28 | 0.98 | 1.06 |
Gross Profit | 7.83 | 6.22 | 2.58 |
Depreciation | 0.49 | 0.43 | 0.42 |
Profit Before Tax | 7.34 | 5.79 | 2.16 |
Tax | 2.01 | 1.55 | 0.62 |
Net Profit | 5.33 | 4.24 | 1.54 |
Quick Links for Samrat Pharmachem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices